Inside the medical demo encounter with Xyrem in narcolepsy/cataplexy clients at therapeutic doses, two clients reported anxiousness and 1 described sleeplessness subsequent abrupt discontinuation for the termination of the clinical demo; in The 2 clients with panic, the frequency of cataplexy experienced increased markedly concurrently.Individuals